# Independent refinement review — PR #109

Reviewer: separate agent `/root/independent_review`, 10 November 2026. Review-only assignment required by the [owner authorization](https://github.com/abuhmaid28/egyhealth360/pull/109#issuecomment-6773923460). I did not implement the gallery, modify production files or change CI policy. Compared the original candidate `87535bb1682b934ec90ed6bff9e66ba3140e331d` with the final refinement worktree. Final published head and CI receipt belong in the PR handoff.

**Verdict: PASS for the bounded high-fidelity candidate review after the context, selection and keyboard corrections below.** This is an independent visual, clinical/privacy and provenance critique, not Product Owner visual approval, backend certification, final Design System acceptance or release permission.

## What I inspected independently

Read AGENTS, the actual owner comment, current status/charter/source index, capability matrix, accepted I3/Slice 2 and I1 operational boundaries, current Pharmacy persistence and organization/membership services. Confirmed the Live adapter/operations exposure gap and future Lab distinction. Inspected all six final before/after Chromium comparison PNGs: Pharmacy AR390 Light and Dark, Laboratory AR390 Light, Admin AR390 Dark, Laboratory AR768 Dark and Admin EN1440 Light. I also opened the actual before/after loopback specimens in a separate Playwright session, exercised the final interactions, and visually inspected Admin AR390 Dark at 200% root text size.

Reviewed screen fingerprints: `screen.js` SHA-256 `21070cc6e60e1f378ed6c009f7edbc3a56bbaf0a5d49d6743679146ca38d7afa`; `screen.css` SHA-256 `9b6f7e05f272d46ec552f170cc3fe8e13548fe8c77c3481b03c4f7c131335846`.

## Visual/task judgment and corrected findings

Pharmacy now leads with a short work title, selected route/status and an expandable route picker. Its chosen-route identity and signed-source specimen remain associated with the review action; reduced-purpose history remains separate. The compact plus affordance makes changing route discoverable without stacking the full queue above the detail. The original large editorial heading and introductory paragraph consumed task space without distinguishing operational context. Their removal is a substantive hierarchy improvement.

Laboratory has a recognizably different workspace: three bordered, numbered conceptual stages and a blank result plane. FUTURE / CONCEPT / NOT LIVE is visible in the screenshot wrapper and panel, with a separate no-actual-result label. Draft invisibility and explicit verification remain legible. The smaller heading and tighter stage blocks improve scanning without populating results or implying live laboratory operation.

Admin now identifies People / Organizations and the exact selected staff membership rather than an abstract access slogan. Selected rows, object-specific organization/account/membership statuses and the shaded membership plane improve list-to-detail reading. The desktop remains sparse because only two synthetic records exist; this is not proof of operational throughput with a populated directory. The nonconnected-management disclosure still consumes mobile space, but its capability truth is necessary.

I raised three correction areas during this one pass:

1. **Pre-action context:** the first refinement placed Admin's review-ending action ahead of membership status and Pharmacy's review ahead of the source-omission caveat. Final specimens now show an explicit illustrative active-membership cue and an item-01/source-omitted/eligibility-unverified cue before their respective actions. These preserve context without reintroducing the original long reading path.
2. **Organizations selection:** selecting the first organization formerly returned navigation to People. The final first organization selection preserves Organizations context; independently verified in browser. The second unimplemented synthetic record still opens uniform unavailable instead of borrowing account A's detail.
3. **Dialog keyboard containment:** the initial measured `trapped:false` result was real: native Chromium Tab could reach document focus rather than remain inside the single-control modal. The final explicit Tab/Shift+Tab handling retains focus on the close control. Independently repeated Tab four times per role, then Escape; focus returned to the triggering review button. This addresses the observed single-control dialog only.

The final AR390 200% Admin heading keeps «الأشخاص» intact on one line; I found no recurrence of the original split-letter issue at that inspected size.

## Independent task-depth confirmation

I independently reproduced the following AR390 Dark measurements at a 390 × 900 viewport. Both themes have identical measured geometry in the author's retained comparison report.

| Role | Action top, before → after | Page height, before → after | Final action bottom |
| --- | --- | --- | --- |
| Pharmacy | 1486 → 687 px | 2094 → 1582 px | 736 px |
| Future Laboratory | 1502 → 989 px | 2133 → 1663 px | 1038 px |
| Admin | 1404 → 942 px | 1958 → 1596 px | 991 px |

Pharmacy's main review action is now fully visible in this initial viewport. Laboratory and Admin still require scrolling: approximately 138 px and 91 px respectively to expose the full action. Their measured improvement is meaningful, but claiming all roles now have an above-fold action would be false. Pixel depth is not a staff time-on-task or usability measurement. The author's 24 locale/theme/320/390 comparisons all reduce action top and page height; I reviewed that report and independently reproduced the three cases above, not all 24.

## Clinical/privacy boundaries

No new live mutation, source value, clinical result, patient chart, clinical count or blanket Admin permission was found. Pharmacy acceptance and full-item dispense remain separate local review explanations. Accepted route B correctly exposes the remaining-item heading and dispense review rather than acceptance. In an independent history browser check, patient identity, current source-item text and action buttons were absent; the reversed FULLY_DISPENSED fact remained explicit. Revoked/denied presentation is a uniform unavailable specimen, not a real authorization test.

Laboratory result content remains blank, with no values, interpretation, LIS/sample pipeline, auto-finalization or doctor-release queue. The future explicit finalization explanation preserves actual editor/verifier attribution and permits same-person entry/verification. Admin's illustrative membership ending retains history and blocks subsequent staff checks without transferring work or creating a clinical grant. Current authority and privacy remain server-side requirements; no static screen can enforce them.

Independent browser observation across all three AR Dark mobile main views found local GET asset requests only, zero external requests, zero localStorage/sessionStorage entries, working skip links and the corrected dialog focus behavior. This does not substitute for backend revocation, wrong-patient suppression, concurrency or real PostgreSQL evidence.

## Provenance and preservation

Independently SHA-256 checked all nine `.reference/` logo/font/license files and byte-compared them with blobs fetched from GitHub. All matched. Independently fetched the nontruncated Brand #101 tree at `687f94074c0ac4d45610546517ea6aa228d36183` and confirmed all nine original source paths map to the manifest's exact blob IDs. Source-exact Arabic/English Light/Dark artwork, Inter and IBM Plex Sans Arabic are preserved; no redraw or recolor was found. Manifest equality does not establish artwork rights clearance.

All 23 original files under the existing evidence directory, including all 18 PNGs and original QA/provenance/review receipts, independently byte-match starting head `87535bb1682b934ec90ed6bff9e66ba3140e331d`. Refined evidence is additive in this subdirectory. Production, API, schema, dependencies and binding contracts remain outside the implementation diff I inspected.

The final author report records 60 responsive cases, 12 text200 cases, 38 alternate-state cases, 12 dialogs and 24 axe audits passing. I inspected those results but did not independently rerun the entire matrix or axe suite. Reported computed text pairs have a minimum 6.27:1 and essential boundary/focus pairs 3.87:1; automated checks do not establish full WCAG conformance.

## Residual tradeoffs and owner stop

Real signed medication/quantity/instruction legibility remains untested because source fields are deliberately omitted; no true clinical fulfillment can be assessed from this specimen. Lab/Admin actions remain below the initial 900 px mobile viewport. The collapsed Pharmacy picker adds one expansion step to change route; queue discovery and density require staff usability work. The sparse desktop list and repeated capability disclosures remain deliberate review limitations rather than a production density solution.

NOT TESTED by this review: clinic users, native Egyptian editorial participants, real clinical data, physical Android/iOS, installed PWA, Safari/Firefox products, actual screen-reader speech, OS font scaling, virtual keyboard, native 400% zoom, print, real authorization/privacy/concurrency, hosted parity or rights/trademark clearance. AP03 and AP05 remain OPEN. Theme default/persistence, candidate staff/Admin navigation, final labels/density, production architecture and high-fidelity adoption remain owner decisions.

Keep PR #109 Draft/Open/Unmerged, auto-merge off. Verify remote CI at the exact new published head separately. **STOP for Product Owner visual approval.**
